Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 18.87%4.35M | 51.76%4.11M | 70.15%4.08M | 29.45%15M | 131.63%6.24M | 30.85%3.66M | -15.55%2.71M | -17.24%2.4M | 46.83%11.59M | -11.42%2.69M |
| Cost of revenue | 18.53%8.8M | 45.06%7.42M | ||||||||
| Gross profit | 48.90%6.2M | 50.10%4.17M | ||||||||
| Operating expense | 25.50%3.81M | 55.88%3.41M | 43.50%3.03M | 16.57%4.76M | 29.87%6.18M | 19.83%3.04M | 14.14%2.19M | -29.71%2.11M | 29.50%4.09M | 453.68%4.76M |
| Staff costs | ---- | ---- | ---- | 51.89%1.1M | ---- | ---- | ---- | ---- | 22.78%726.39K | ---- |
| Depreciation and amortization | ---- | ---- | ---- | -23.15%1.15M | ---- | ---- | ---- | ---- | 76.60%1.5M | ---- |
| -Depreciation | ---- | ---- | ---- | -33.31%790.25K | ---- | ---- | ---- | ---- | 39.46%1.19M | ---- |
| -Amortization | ---- | ---- | ---- | 14.99%362.97K | ---- | ---- | ---- | ---- | --315.66K | ---- |
| Other operating expenses | 23.08%3.94M | 50.31%3.59M | 52.17%3.22M | 45.78%2.74M | 26.50%6.24M | 24.39%3.2M | 24.79%2.39M | -29.75%2.12M | 6.43%1.88M | 274.60%4.93M |
| Total other operating income | -23.27%122K | -9.31%185K | 2,337.50%195K | 1,159.89%230.61K | -66.86%57K | 354.29%159K | --204K | -38.46%8K | -63.49%18.3K | 554.29%172K |
| Operating profit | -13.78%532K | 34.36%696K | 265.85%1.05M | 1,733.15%1.44M | 102.76%57K | 139.15%617K | -59.75%518K | 373.33%287K | 120.60%78.45K | -184.01%-2.07M |
| Net non-operating interest income (expenses) | -825.00%-74K | -228.57%-23K | -212.50%-25K | 138.62%123.81K | -40.00%-21K | 46.67%-8K | 56.25%-7K | 46.67%-8K | -14.64%51.89K | -117.28%-15K |
| Non-operating interest income | ---- | ---- | ---- | 68.82%191.03K | ---- | ---- | ---- | ---- | 10.66%113.16K | ---- |
| Non-operating interest expense | 825.00%74K | 228.57%23K | 212.50%25K | 9.71%67.22K | 40.00%21K | -46.67%8K | -56.25%7K | -46.67%8K | 47.74%61.27K | -3.04%15K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 99K | 13K | 121K | 643.41K | 643K | 0 | 0 | 0 | 0 | 0 |
| Special income (charges) | 84.72%-130.47K | -275.66%-853.83K | ||||||||
| Less:Other special charges | ---- | ---- | ---- | 97.19%-1.5K | ---- | ---- | ---- | ---- | ---53.41K | ---- |
| Less:Write off | ---- | ---- | ---- | -85.45%131.97K | ---- | ---- | ---- | ---- | 286.65%907.24K | ---- |
| Other non-operating income (expenses) | -85.52%5K | 34.54K | ||||||||
| Income before tax | -8.69%557K | 34.25%686K | 310.75%1.15M | 401.90%2.08M | 132.66%680K | 151.03%610K | -59.80%511K | 332.50%279K | -514.88%-688.96K | -1,243.75%-2.08M |
| Income tax | -24.03%177K | 52.47%247K | 126.32%258K | 13.28%514.64K | 102.86%6K | 47.47%233K | -58.67%162K | -0.87%114K | -25.07%454.33K | -814.99%-210K |
| Net income | 0.80%380K | 25.79%439K | 437.58%887K | 236.91%1.57M | 136.00%674K | 343.53%377K | -60.30%349K | 170.21%165K | -159.65%-1.14M | -915.67%-1.87M |
| Net income continuous operations | 0.80%380K | 25.79%439K | 438.18%888K | 236.91%1.57M | 136.00%674K | 343.53%377K | -60.30%349K | 170.21%165K | -159.65%-1.14M | -915.67%-1.87M |
| Noncontrolling interests | -40.43%168K | 52K | 167K | 312.61K | 313K | 282K | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 123.16%212K | 10.89%387K | 336.97%721K | 209.57%1.25M | 119.34%362K | 11.76%95K | -60.30%349K | 170.21%165K | -159.65%-1.14M | -915.67%-1.87M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 123.16%212K | 10.89%387K | 336.97%721K | 209.57%1.25M | 119.34%362K | 11.76%95K | -60.30%349K | 170.21%165K | -159.65%-1.14M | -915.67%-1.87M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 100.00%0.0008 | 0.00%0.0012 | 500.00%0.0024 | 210.00%0.0044 | 117.65%0.0012 | 0.00%0.0004 | -62.50%0.0012 | 150.00%0.0004 | -150.00%-0.004 | -750.00%-0.0068 |
| Diluted earnings per share | 100.00%0.0008 | 0.0012 | 500.00%0.0024 | 210.00%0.0044 | 117.65%0.0012 | 0.00%0.0004 | 0 | 150.00%0.0004 | -150.00%-0.004 | -750.00%-0.0068 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.